---
title: "Public Acceptability of Self-Payment for Community Pharmacists' Services — National Survey Results"
id: "medrxiv-29-public-acceptability-of-self-payment-for-community-pharmacists-services-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-29-public-acceptability-of-self-payment-for-community-pharmacists-services-a"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.15.26368139v1?rss=1"
published_at: "2026-11-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Public Acceptability of Self-Payment for Community Pharmacists' Services — National Survey Results
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-29-public-acceptability-of-self-payment-for-community-pharmacists-services-a
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.15.26368139v1?rss=1)
- **Published At:** 2026-11-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used a cross-sectional, national online survey of U.S. adults conducted in spring 2026; investigators applied a between-subjects randomized payment-framing design assigning participants to a **$20** stated-price condition or an 'any amount' condition. - Primary outcomes were binary judgments of payment acceptability for multiple pharmacist-provided and related health services; secondary outcomes collected trust measures and demographic characteristics. - A total of 1,069 respondents completed the survey; respondents in the **$20** condition rated self-payment more favorably than those asked about 'any amount of money.' - Agreement in the **$20** stated-price arm was highest for **osteoporosis screening** (75.8%) and travel-related vaccines (69.0%). - Lowest acceptability rates in the **$20** arm were for antibiotic use consultation (23.9%) and wound care (32.1%), indicating substantial heterogeneity by service type. - Statistical associations: older respondents and Hispanic respondents had lower odds of viewing self-payment as acceptable; men and respondents reporting greater **pharmacist trust** had higher odds of acceptability. - The authors reported IRB approvals from Western New England University and UC San Diego; they used a non-probability sampling approach and stated that all data are contained within the manuscript. - The source did not report response rates, specific recruitment platforms, or detailed survey instrument psychometrics within the abstract; those methodological details therefore are not available in the source text.
## Clinical Analysis & Structured Key Points
Public Acceptability of Self-Payment for Community Pharmacists' Services: A National Online Survey | medRxiv Skip to main content Public Acceptability of Self-Payment for Community Pharmacists' Services: A National Online Survey Kimberly Pesaturo , John-Henry Pezzuto , Melissa Mattison , John M. Pezzuto doi: https://doi.org/10.64898/2026.11.15.26368139 Kimberly Pesaturo 1 Western New England University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: kimberly.pesaturo{at}wne.edu John-Henry Pezzuto 2 UC San Diego; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Melissa Mattison 3 Western New England Univeristy Find this author on Google Scholar Find this author on PubMed Search for this author on this site John M. Pezzuto 1 Western New England University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background The traditional business model for sustaining United States (U.S.) community pharmacies has relied on income generated by product sales. A fee-for-service model could help alleviate insufficient profit by monetizing conventionally free pharmacy services if patients are willing to pay out-of-pocket. Objectives This study evaluated public acceptability of out-of-pocket payment for community pharmacist-provided services, variation in payment acceptability across services, and assessed whether payment acceptability differed by respondent characteristics and trust constructs. Methods This study represents a cross-sectional online survey of U.S. adults conducted during spring 2026 using a non-probability sampling approach. Primary outcomes were binary stated payment-acceptability judgments for a variety of pharmacist and health services. The survey used a between-subjects randomized payment-framing design, where participants were assigned to either a stated-price condition or an any-payment condition. Secondary outcomes included trust designations and participant demographic characteristics. Results A total of 1069 respondents completed the survey. A $20 fee was viewed more favorably than a general "any amount of money" fee. In the $20 stated-price condition, agreement was highest for osteoporosis screening (75.8%) and travel-related vaccines (69.0%), and lowest for antibiotic use consultation (23.9%) and wound care (32.1%). Older respondents and Hispanic respondents were less likely to view payment as acceptable, whereas men and respondents with greater pharmacist trust were more likely to view payment as acceptable. Conclusion Although patients historically have received many community pharmacy services at no cost, this study demonstrates that the concept of self-payment ifor certain services is considered acceptable, especially for services not typically provided. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Board of Western New England University reviewed with study (No. 316) and ethical approval was given. The Institutional Review Board of the University of California, San Diego reviewed this study (No. 812140) and approval was given. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Posted November 17, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Public Acceptability of Self-Payment for Community Pharmacists' Services: A National Online Survey Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Public Acceptability of Self-Payment for Community Pharmacists' Services: A National Online Survey Kimberly Pesaturo , John-Henry Pezzuto , Melissa Mattison , John M. Pezzuto medRxiv 2026.11.15.26368139; doi: https://doi.org/10.64898/2026.11.15.26368139 Share This Article: Copy Citation Tools Public Acceptability of Self-Payment for Community Pharmacists' Services: A National Online Survey Kimberly Pesaturo , John-Henry Pezzuto , Melissa Mattison , John M. Pezzuto medRxiv 2026.11.15.26368139; doi: https://doi.org/10.64898/2026.11.15.26368139 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (642) Allergy and Immunology (925) Anesthesia (355) Cardiovascular Medicine (5043) Dentistry and Oral Medicine (496) Dermatology (431) Emergency Medicine (681) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1702) Epidemiology (16325) Forensic Medicine (36) Gastroenterology (1245) Genetic and Genomic Medicine (7312) Geriatric Medicine (758) Health Economics (1099) Health Informatics (5327) Health Policy (1479) Health Systems and Quality Improvement (1844) Hematology (600) HIV/AIDS (1386) Infectious Diseases (except HIV/AIDS) (16520) Intensive Care and Critical Care Medicine (1206) Medical Education (702) Medical Ethics (157) Nephrology (755) Neurology (7644) Nursing (380) Nutrition (1138) Obstetrics and Gynecology (1302) Occupational and Environmental Health (1045) Oncology (3758) Ophthalmology (1101) Orthopedics (413) Otolaryngology (470) Pain Medicine (506) Palliative Medicine (144) Pathology (724) Pediatrics (1872) Pharmacology and Therapeutics (758) Primary Care Research (789) Psychiatry and Clinical Psychology (6169) Public and Global Health (10035) Radiology and Imaging (2550) Rehabilitation Medicine and Physical Therapy (1533) Respiratory Medicine (1277) Rheumatology (663) Sexual and Reproductive Health (811) Sports Medicine (601) Surgery (807) Toxicology (109) Transplantation (320) Urology (309)
## Related Clinical Research

- [GLP-1 Agonist Use Associated with Faster Bowel Recovery After Lumbar Fusion](https://medichelpline.com/clinical-feed/pubmed-41400023.md) (DOI: 10.1097/BRS.0000000000005598)
- [Diabetic Peripheral Neuropathy and Low Appendicular Muscle Mass Linked to Osteoporosis, Falls, and](https://medichelpline.com/clinical-feed/pubmed-42949208.md) (DOI: 10.1111/1753-0407.70276)
- [Law Must Address 340B Treatment of Orphan-Designated Drugs Used for Multiple Conditions](https://medichelpline.com/clinical-feed/stat-news-1-opinion-the-law-has-to-catch-up-on-orphan-designated-drugs-with-multiple-uses.md)
- [Regulation of Kratom and 7-OH: Experts Call for Action and Debate Solutions](https://medichelpline.com/clinical-feed/stat-news-1-kratom-and-7-oh-should-be-regulated-experts-agree-they-re-split-on-how.md)
- [Community pharmacists’ roles and barriers in health promotion and disease prevention in Jordan: CO](https://medichelpline.com/clinical-feed/plos-one-8-factors-influencing-community-pharmacists-provision-of-health-promotion-and.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.